Caulkett Nigel, Read Matt, Fowler David, Waldner Cheryl
Department of Small Animal Clinical Sciences, Western College of Veterinary Medicine, 52 Campus Drive, Saskatoon, Saskatchewan S7N 5B4.
Can Vet J. 2003 Jul;44(7):565-70.
This study was designed to compare the analgesic effects of butorphanol with those of meloxicam following ovariohysterectomy. Fifteen dogs were premedicated with 0.05 mg/kg body weight (BW) of acepromazine by intramuscular (IM) injection, plus 0.2 mg/kg BW of meloxicam by subcutaneous (SC) injection. Fifteen dogs were premedicated with 0.05 mg/kg BW of Acepromazine, IM, plus 0.2 mg/kg BW of butorphanol, IM. Anesthesia was induced with thiopental, and dogs were maintained on halothane. All pain measurements were performed by 1 experienced individual, blinded to treatment. Pain scores and visual analogue scales (VAS) were performed at 2, 3, 4, 6, 8, 12, and 24 hours postpremedication. An analgesiometer was used to determine the pressure required to produce an active avoidance response to pressure applied at the incision line. Pain scores, VAS, and analgesiometer scores were analyzed by using a generalized estimating equations method. A significance level of P < 0.05 was considered significant. Animals that received meloxicam demonstrated significantly lower pain scores and VAS than did animals that received butorphanol in the first 12 hours after surgery. Results of this study suggest that meloxicam will produce better postoperative analgesia than will butorphanol. Mucosal bleeding times were performed on cooperative animals in the study group (11 butorphanol, 13 meloxicam). Bleeding times were performed prior to premedication, 6 hours following premedication, and 24 hours after premedication. The 6- and 24-hour readings were compared with baseline bleeding times by using a paired t-test with a Bonferroni correction (a significance level of P < 0.025). Bleeding times did not change significantly over time.
本研究旨在比较布托啡诺与美洛昔康在卵巢子宫切除术后的镇痛效果。15只犬通过肌肉注射(IM)给予0.05mg/kg体重(BW)的乙酰丙嗪进行术前用药,再通过皮下注射(SC)给予0.2mg/kg BW的美洛昔康。另外15只犬通过IM给予0.05mg/kg BW的乙酰丙嗪进行术前用药,再通过IM给予0.2mg/kg BW的布托啡诺。用硫喷妥钠诱导麻醉,犬维持使用氟烷。所有疼痛测量均由1名经验丰富的人员进行,该人员对治疗情况不知情。在术前用药后2、3、4、6、8、12和24小时进行疼痛评分和视觉模拟量表(VAS)评估。使用痛觉计确定在切口线施加压力以产生主动回避反应所需的压力。采用广义估计方程法分析疼痛评分、VAS和痛觉计评分。P<0.05的显著性水平被认为具有统计学意义。在术后前12小时内,接受美洛昔康的动物的疼痛评分和VAS显著低于接受布托啡诺的动物。本研究结果表明,美洛昔康比布托啡诺能产生更好的术后镇痛效果。在研究组(11只布托啡诺组、13只美洛昔康组)中对配合的动物进行黏膜出血时间测定。在术前用药前、术前用药后6小时和术前用药后24小时进行出血时间测定。采用配对t检验并进行Bonferroni校正(显著性水平P<0.025),将6小时和24小时的读数与基线出血时间进行比较。出血时间随时间没有显著变化。